- Home
- ABVX vs BYD Comparison
ABVX vs BYD Comparison
Compare ABVX & BYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABVX | BYD |
|---|---|---|
| Founded | 2013 | 1973 |
| Country | France | United States |
| Employees | 69 | N/A |
| Industry | | Hotels/Resorts |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 5.9B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | ABVX | BYD |
|---|---|---|
| Price | $99.74 | $87.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 11 |
| Target Price | ★ $131.31 | $90.82 |
| AVG Volume (30 Days) | ★ 2.0M | 907.7K |
| Earning Date | 03-23-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 264.46 |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $2,626,730,000.00 |
| Revenue This Year | $52.14 | $1.71 |
| Revenue Next Year | $4,132.27 | $2.74 |
| P/E Ratio | ★ N/A | $64.51 |
| Revenue Growth | N/A | ★ 9.41 |
| 52 Week Low | $5.75 | $73.00 |
| 52 Week High | $148.83 | $89.96 |
Technical Indicators
Market Signals| Indicator | ABVX | BYD |
|---|---|---|
| Relative Strength Index (RSI) | 42.53 | 60.09 |
| Support Level | $83.85 | $80.76 |
| Resistance Level | $131.50 | $88.54 |
| Average True Range (ATR) | 7.78 | 2.09 |
| MACD | -3.17 | 0.96 |
| Stochastic Oscillator | 45.16 | 79.81 |
Price Performance
Historical ComparisonAbout ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
About BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. The Midwest and South hold the key number of entertainment properties and generate the majority of the company's revenue.